Micro-anatomy of the renal sympathetic nervous system: A human postmortem histologic study

Clinical Anatomy

Volumn 25, Issue 5, 2012, Pages 628-633

  Atherton, Daniel S ^a   Deep, Nicholas L ^b   Mendelsohn, Farrell O ^c  

^a Baptist Health System   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c Princeton Baptist Birmingham   (United States)

Author keywords

device therapy; hypertension; renal denervation

Indexed keywords

ADRENERGIC SYSTEM; ADULT; AGED; ANATOMY; ARTERY INTIMA; ARTICLE; AUTOPSY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY; KIDNEY DENERVATION; MALE; NERVE; PRIORITY JOURNAL; RENAL ARTERY; SYMPATHETIC NERVE;

ADULT; AGED; AUTOPSY; CATHETER ABLATION; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84861812398     PISSN: 08973806     EISSN: 10982353     Source Type: Journal    
DOI: 10.1002/ca.21280     Document Type: Article

References (16)

1. Atherton DS, Mendelsohn FO,. 2011. Anatomic study of the renal sympathetic nervous system. Mod Pathol 24: 389A.
2. Avitall B, Helms R,. 2000. Determinants of Radiofrequency-Induced Lesion Size. In:, Huang SKS, Wilber DJ, editors. Radiofrequency Catheter Ablation of Cardiac Arrhythmias: Basic Concepts and Clinical Applications. 2nd Ed. Armonk, NY: Futura Publishing Company. p 47-80.
3. DiBona GF,. 2005. Physiology in perspective: The wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289: R633-R641.
4. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G,. 1991. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension 17: III29-III35.
5. Holmes D, Fish JM, Byrd IA, Dando JD, Fowler SJ, Cao H, Jensen JA, Puryear HA, Chinitz LA,. 2011. Contact sensing provides a highly accurate means to titrate radiofrequency ablation lesion depth. J Cardiovasc Electrophysiol 22: 684-690.
6. Hua XY, Theodorsson-Norheim E, Lundberg JM, Kinn AC, Hökfelt T, Cuello AC,. 1987. Co-localization of tachykinins and calcitonin gene-related peptide in capsaicin-sensitive afferents in relation to motility effects on the human ureter in vitro. Neuroscience 23: 693-703.
7. Kaplan NM,. 2005. Resistant hypertension. J Hypertens 23: 1441-1444.
8. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J,. 2005. Global burden of hypertension: Analysis of worldwide data. Lancet 365: 217-223.
9. Knight DS, Cicero S, Beal JA,. 1991. Calcitonin gene-related peptide-immunoreactive nerves in the rat kidney. Am J Anat 190: 31-40.
10. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M,. 2009. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 373: 1275-1281.
11. Owens CD,. 2010. "Adventitial Drug-Induced Renal Artery Denervation in Refractory Hypertension: Preclinical Experience and First-in-Human Plans." Transcatheter Cardiovascular Therapeutics 2010. University of California, San Francisco. 21 Sept. 2010. Lecture.
12. Page IH, Heuer GJ,. 1935. The effect of renal denervation of patients suffering from nephritis. J Clin Invest 14: 443-458.
13. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD,. 2004. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43: 169-175.
14. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD,. 2009. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361: 932-934.
15. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M,. 2010. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomized controlled trial. Lancet 376: 1903-1909.
16. Wyss JM, Carlson SH,. 1999. The role of the central nervous system in hypertension. Curr Hypertens Rep 1: 246-253.